NCT00671697View on ClinicalTrials.gov

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

May 31, 2011

Conditions
Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
Interventions
DRUG

Arsenic Trioxide

DRUG

Decitabine

Trial Locations (1)

63110

Washington University, St Louis

Sponsors

Collaborators (1)

Cephalon
All Listed Sponsors
collaborator

Cephalon

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00671697 - Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter